Live Bacil Pharma Share Price Chart

O 19.6

H 19.6

L 19.6

VOL 500

Bacil Pharma Performance

Days Range

Low: ₹19.50
High: ₹19.60
Previous Close ₹19.22
Open ₹19.60
Volume 900
Day’s Range ₹19.50 - ₹19.60
52W Range ₹4.68 - ₹19.60
Market Cap ₹11.32 Cr

Bacil Pharma Fundamentals

ROCE (TTM) -9.0117
P/E Ratio (TTM) 0
P/B Ratio 18.68
Industry P/E 44.62
Debt to Equity 0.02
ROE -9.2335
EPS (TTM) 0
Dividend Yield 0
Book Value 1.03
Face Value 10

Bacil Pharma Financials

Mar 2023Jun 2023Sep 2023Dec 2023
Net Sales0000
Expenses0.080.030.040.06
Profit before tax-0.080.02-0.01-0.02
Operating Profit-0.080.02-0.01-0.02
Net Profit-0.080.02-0.01-0.02
EPS in Rs-0.130.03-0.02-0.04

About Bacil Pharma

Incorporated as a private limited company in Maharashtra in May '87, Bacil Pharma (BPL) was converted into a public limited company in Oct.'90. The main business activity of the Company is Pharmaceuti ... Read More

Parent Organisation Indian Private
Founded 1987
Managing Director
BSE Symbol BACPHAR

Peer Comparison

Stocks Market Cap (cr) Market Price (₹) 52 Week Low-High (₹)
Supriya Lifescience Ltd ₹3,140.84

394.3

3.70 (0.95%)

390.2 - 406View Peer Comparison
Celestial Biolabs Ltd ₹4.56

1.75

0.00 (0.00)

1.75 - 1.8View Peer Comparison
JFL Life Sciences Ltd ₹44.38

40.9

0.55 (1.36%)

39.15 - 40.9View Peer Comparison
Procter & Gamble Health Ltd ₹7,802.83

4705.55

4.45 (0.09%)

4701.05 - 4825View Peer Comparison
Veerhealth Care Ltd ₹41.14

26

0.00 (0.00)

26 - 26View Peer Comparison

What's Trending

Bacil Pharma FAQs

What is the Share price of Bacil Pharma (BACPHAR)?

Bacil Pharma (BACPHAR) share price as of April 23, 2024, on BSE is Rs 19.50 (BSE).

Can I buy Bacil Pharma (BACPHAR) shares?

Yes, You can buy Bacil Pharma (BACPHAR) shares by opening a Demat account with Angel One.

How do I buy Bacil Pharma (BACPHAR) from Angel One?

Bacil Pharma (BACPHAR) share can be brought through the following modes:
  1. Direct investment: You can buy Bacil Pharma (BACPHAR) shares by opening a Demat account with Angel One.
  2. Indirect investment: The indirect method involves investing through ETFs and Mutual Funds that offer exposure to Bacil Pharma (BACPHAR) shares.